
Gene Editing May Help Treat Dangerously High Cholesterol with Just One Infusion
Gene editing may help people born with dangerously high cholesterol lower their levels with just one infusion.

Gene editing may help people born with dangerously high cholesterol lower their levels with just one infusion.

How the brain clears its waste could help researchers combat neurodegenerative diseases and age-related cognitive decline.

Coredio’s AI software is used to monitor HF parameters via wearables and standard blood pressure cuffs.

MannKind (Nasdaq:MNKD) announced today that it received FDA approval for its Afrezza inhaled insulin powder for children.

A new brain imaging test can detect a key hallmark of Alzheimer’s disease before symptoms appear and earlier than the method currently used in clinical practice in the United States and Europe, report University of Pittsburgh School of Medicine researchers in The Lancet.

Researchers at the University Medical Center Göttingen (UMG) and the University Hospital of Schleswig-Holstein (UKSH) have made a significant breakthrough in the treatment of severe heart failure: For the first time, a clinical trial has demonstrated that laboratory-grown heart muscle tissue can improve the pumping function of damaged hearts.

Scientists have developed a powerful new technique that allows them to observe how individual cells manufacture proteins during aging, offering an unprecedented glimpse into the hidden molecular activity of stem cells in living tissue.

Brain tumor growth may depend not only on cancer-causing mutations, but also on the molecular conditions in specific brain regions.

Decnupaz is the first antibody-drug conjugate for blastic plasmacytoid dendritic cell neoplasm, an ultra-rare and aggressive blood cancer.

Procept BioRobotics (Nasdaq:PRCT) announced today that it received FDA investigational device exemption (IDE) for a second Aquablation evaluation.